AUTHOR RIGHTS AND OPEN ACCESS PDF Print E-mail

 

Author rights


As an author, you are granted rights for a large number of author uses, including use by your employer (institution or company). These rights are granted and permitted without the need to obtain specific permission from the copyright holder, AlphaMed Press, provided a full credit line is prominently placed (i.e., author name(s), journal name, copyright year, volume number, inclusive pages, and copyright holder). These author rights are granted and apply only to articles for which you are named as the author or co-author. The author rights include:

  • The right to make copies of the article for your own personal use, including for your own classroom teaching use;
  • The right to make copies and distribute copies (including via e-mail) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g., via an e-mail list or listserv);
  • The right to present the article at a meeting or conference and to distribute copies of such paper or article to the delegates attending the meeting;
  • For the author’s employer, if the article is a “work for hire,” made within the scope of the author’s employment, the right to use all or part of the information in (any version of) the article for other intracompany use (e.g., training);
  • Patent and trademark rights and rights to any process or procedure described in the article;
  • The right to include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);
  • The right to use the article or any part thereof in a printed compilation of works of the author, such as collected writings or lecture notes (subsequent to publication of the article in the Journal);
  • The right to prepare other derivative works, to extend the article into book-length form, or to otherwise reuse portions or excerpts in other works, with full acknowledgment of its original publication in the journal; and
  • The right to self-archive the work by posting the work as the final peer-reviewed author’s manuscript (but not published layout) on their own website and their institution’s website (website only, NOT repository) no earlier than 6 months after print publication in The Oncologist provided that a link is made to the AlphaMed Press version.

NIH-funded articles
Pursuant to NIH mandate, the accepted version of contributions authored by NIH grant-holders will be posted to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see http://publicaccess.nih.gov.

Wellcome Trust-funded articles
Since October 1, 2006, Wellcome Trust grantees are required to submit an electronic copy of the final manuscripts of their research papers to PMC or UKPubMed Central (UKPMC). The Wellcome Trust requires that the author’s work be made available to the public via PMC and PMC mirror sites no later than six months after final publication. AlphaMed Press has established a policy that will allow authors who publish in The Oncologist to comply with these requirements.

AlphaMed Press authorizes Wellcome Trust-funded authors whose papers are accepted and published in The Oncologist permission to deposit the author’s peer-reviewed manuscript (but not published format) in PMC and UKPMC no earlier than six months after the print publication in The Oncologist. Additionally, the author is authorized to replace the peer-reviewed author manuscript with the final published version 12 months after print publication in The Oncologist. Further information on the Wellcome Trust policy is available at: http://www.wellcome.ac.uk/node3302.html.

Howard Hughes Medical Institute (HHMI)-funded articles

The Institute's policy on public access to publications takes effect for manuscripts submitted for publication on or after January 1, 2008 for which an HHMI scientist is a major author. HHMI has designated PubMed Central (PMC) as the repository for journals in the biological sciences. Articles are expected to be deposited in PMC and also made publicly available online within six months of publication. The HHMI will reimburse authors up to $2,000 per paper for open access publisher fees. AlphaMed Press provides an Open Access Option (described below) that complies fully with the HHMI requirements. Further information on the HHMI policy is available at: http://www.hhmi.org/about/research/papp.html .

Open Access option

AlphaMed Press offers authors the option of making their article freely available immediately after publication on The Oncologist website. This option provides support to authors who wish or need to sponsor open access to their published research articles. This open access option provides a fee-based mechanism for individual authors or their research funding agencies to sponsor the open availability of their articles on the web at the time of initial publication. Additionally, under this open access option, AlphaMed Press will allow the deposition of the final paper to PMC and its international equivalent UKPMC on publication. The fee per article for this service is $2,000 USD in addition to the regular publication fee charged to authors.

The open access option will be made available to authors only after peer-review and editorial acceptance of their articles for publication in order to prevent any potential conflicts of interest. Open Access is not available for CME.articles.

.
 


 

TO_Appbutton

reflections